DCGI approves indigenous mRNA Covid jab for emergency use in 18 years & above; Covovax for 7-11 years
NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19...
DCGI
Biological E’s Corbevax gets DCGI nod as a heterologous Covid-19 booster dose
NEW DELHI: Biological E’s Corbevax becomes the first vaccine to get the Drug Controller General of India’s (DCGI) nod to...
DCGI grants EUA to ZycovD COVID-19 vaccine for two-dose regimen for children above 12
NEW DELHI: Zydus Lifesciences Ltd., a discovery driven global lifesciences company announced that its novel COVID-19 vaccine, ZyCoV-D has received...
Zydus Lifesciences receives DCGI approval for Oxemia
NEW DELHI: Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), a discovery-driven, global lifesciences company announced that it has...
Bharat Biotech seeks full marketing approval from DCGI for Covaxin
NEW DELHI: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine...
DCGI nod to Phase III trials of two-dose Zydus Covid-19 vaccine
NEW DELHI: The Drugs Controller General of India (DCGI) has permitted Zydus Cadila to conduct Phase III trials of ZyCoV-D,...
DCGI nod to phase-I clinical trial of Reliance Life Sciences’ Covid-19 vaccine
NEW DELHI: The Drugs Controller General of India (DCGI) on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences...
Covid-19 vaccine: Zydus applies to the DCGI for EUA to launch ZyCoV-D
NEW DELHI: Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to the office of...
Zydus seeks DCGI approval for clinical trial of monoclonal antibodies cocktail
NEW DELHI: SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases...
India approves Phase II/III clinical trial of COVAXIN in age group of 2 to 18 Years
NEW DELHI: The National Regulator of India, the Drugs Controller General of India (DCGI), after careful examination, has accepted the...
